Clinical Trials Browser

Phase 2 × CK-2017357 × Clear all

NCT01268280 2019-09-24

Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

Phase 2 Terminated

Myasthenia Gravis